TNBC is a subtype of breast cancer with high malignancy, easy recurrence and metastasis, and poor prognosis; it is insensitive to endocrine therapy and traditional anti-HER2 targeted therapy, and chemotherapy is the main therapeutic strategy. The gene discussed is ERBB2; the disease is breast carcinoma.